Mouse CXCL13/BLC/BCA-1 Quantikine ELISA Kit

Name Mouse CXCL13/BLC/BCA-1 Quantikine ELISA Kit
Supplier R&D Systems
Catalog MCX130
Category ELISA Kit
Prices $479.00
Sizes 1 kit
Assay Type Solid Phase Sandwich ELISA
Sample Type Cell Culture Supernates (50 uL), Serum (13 uL), EDTA Plasma (13 uL), Heparin Plasma (13 uL)
Sensitivity 2.84 pg/mL
Range 15.6 - 1,000 pg/mL (Cell Culture Supernates, Serum, EDTA Plasma, Heparin Plasma)
Format 96-well strip plate
Applications ELISA
Species Reactivities Mouse
Description The Quantikine Mouse BLC/BCA-1 Immunoassay is a 4.5 hour solid-phase ELISA designed to measure mouse BLC/BCA-1 in cell culture supernates, serum, and plasma
Gene CXCL13
Supplier Page Shop

Product images


Product References

Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic - Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic

Lee KE, Spata M, Bayne LJ, Buza EL, Durham AC, Allman D, Vonderheide RH, Simon MC. Cancer Discov. 2016 Mar;6(3):256-69.

Brain inflammation is accompanied by peripheral inflammation in Cstb -/- mice, a - Brain inflammation is accompanied by peripheral inflammation in Cstb -/- mice, a

Okuneva O, Li Z, Korber I, Tegelberg S, Joensuu T, Tian L, Lehesjoki AE. J Neuroinflammation. 2016 Nov 28;13(1):298.

Prion infection of mouse brain reveals multiple new upregulated genes involved in - Prion infection of mouse brain reveals multiple new upregulated genes involved in

Carroll JA, Striebel JF, Race B, Phillips K, Chesebro B. J Virol. 2015 Feb;89(4):2388-404.

Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in - Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in

Grabner R, Lotzer K, Dopping S, Hildner M, Radke D, Beer M, Spanbroek R, Lippert B, Reardon CA, Getz GS, Fu YX, Hehlgans T, Mebius RE, van der Wall M, Kruspe D, Englert C, Lovas A, Hu D, Randolph GJ, Weih F, Habenicht AJ. J Exp Med. 2009 Jan 16;206(1):233-48.

Cyclooxygenase inhibition during allergic sensitization increases - Cyclooxygenase inhibition during allergic sensitization increases

Zhou W, Newcomb DC, Moore ML, Goleniewska K, O'Neal JF, Peebles RS Jr. J Immunol. 2008 Oct 15;181(8):5360-7.

Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates - Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates

Pierce EM, Carpenter K, Jakubzick C, Kunkel SL, Flaherty KR, Martinez FJ, Hogaboam CM. Am J Pathol. 2007 Apr;170(4):1152-64.

The chemokine decoy receptor M3 blocks CC chemokine ligand 2 and CXC chemokine - The chemokine decoy receptor M3 blocks CC chemokine ligand 2 and CXC chemokine

Martin AP, Canasto-Chibuque C, Shang L, Rollins BJ, Lira SA. J Immunol. 2006 Nov 15;177(10):7296-302.